An evaluation of 10 percent and 20 percent benzocaine gels in patients with acute toothaches
Elliot V. Hersh(University of Pennsylvania), Sharon M. Gordon(University of Maryland, Baltimore), Paul A. Moore(Zymeworks (Canada)), Jillian Wallen, Paul Creighton(Buffalo State University), Othman Shibly(Buffalo State University), Stanley N. Turetzky(New York University), Rina Leyva(Pfizer (United Kingdom)), Tanya Mathew(The Ohio State University), Arthur S. Kuperstein(University of Pennsylvania), Cynthia Idzik-Starr(University of Maryland, Baltimore), Sebastian G. Ciancio(Universidad Complutense de Madrid), Gary E. Jeffers(University of Detroit Mercy), Steven C. Levine(University of Pittsburgh), Paul S. Casamassimo(Nationwide Children's Hospital), Eric T. Stoopler(University of Pennsylvania), Patricia Corby(New York University), Athena Papas(Tufts University), Sean G. Boynes(University of Pittsburgh)
Cited by 25
Related Papers
Monitoring Sedation Status Over Time in ICU Patients
|JAMA|2003|1.7k
CD133/prominin-1 is a potential therapeutic target for antibody-drug conjugates in hepatocellular and gastric cancers
|British Journal of Cancer|2008|289
Long-term Cognitive and Psychological Outcomes in the Awakening and Breathing Controlled Trial
|American Journal of Respiratory and Critical Care Medicine|2010|251
Dual checkpoint targeting of B7-H3 and PD-1 with enoblituzumab and pembrolizumab in advanced solid tumors: interim results from a multicenter phase I/II trial
|Journal for ImmunoTherapy of Cancer|2022|140